| Fund ID | 805-7535834934 |
| Fund type | Private Equity Fund |
| 3(c)(1) exclusion | No |
| 3(c)(7) exclusion | Yes |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | Yes |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| % of assets independently valued | 0% |
| Owned by the adviser or related persons | 3% |
| Owned by funds of funds | 30% |
| Owned by non-U.S. persons | 18% |
| Fund | Type | Gross assets |
|---|---|---|
| Frazier Life Sciences Public Fund, L.P. | Hedge | $1.25B |
| Frazier Life Sciences XI, L.P. | Venture Capital | $549.2M |
| Frazier Life Sciences IX, L.P. | Venture Capital | $489.6M |
Frazier Life Sciences X, L.P. reports $623.3 million in gross assets, among the top 11% of private funds by size.
The stated minimum investment is $3 million.
Frazier Life Sciences X, L.P. is managed by Frazier Life Sciences Management, LP.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.